The annual report on the most valuable pharmaceutical brands.
Abbott has been ranked as one of the world’s top ten pharmaceutical brands for the first time. With a 77% brand value growth to US$3.7 billion, American pharma giant Abbott enters the Brand Finance Pharmaceuticals 10 ranking in 4th place following its acquisition and rebranding of medical device firm St. Jude Medical and diagnostic-testing company Alere, which were both successfully completed last year.
Abbott’s intelligent M&A activity combined with a clear strategy in extending the Abbott brand, has boosted its performance this year. Abbott enters the top ten ranking with an impressive 4th place debut, firmly positioning itself as a global leader in medical products. Whilst Roche has remained steady at the top of the ranking, Abbott is growing rapidly and may challenge for the top spots if it sustains this promising growth in the future.
Read about this and many more insights in the full report, available for download now.